Why do our bodies not only fail to learn from prior dengue infection but also become more vulnerable to it as a result? New research pinpoints a subgroup of antibodies that may be to blame.
Jan and Marder, who have both made fundamental contributions to neurobiology, were presented with the award in a ceremony on The Rockefeller University campus on September 20.
As with many cutting-edge therapies, we know more about the drug's effectiveness than we do about how it actually operates. A new study reveals a possible mechanism for its impact on patients.
Patients with a specific cocktail of COVID exposure had the highest level of antibodies against SARS-CoV-2 and its variants, which also provided a strong immunological shield for their babies.
Sponsored by the Office for Diversity, Equity, and Inclusion, the event brought together land stewards from across the city in an effort to make soil science more accessible to the local community.
One clever way to observe the neural activity of Drosophilae: build them a custom fly treadmill and tempt them with the tangy perfume of apple cider vinegar.
Birsoy is honored for groundbreaking research uncovering metabolic weaknesses of diseased cells, such as cancer, while shedding light on debilitating mitochondrial diseases and rare genetic disorders.
With 40% of encephalitis cases now explained by an autoimmune deficiency, West Nile virus "is by far the best understood human infectious disease in the world. It’s stunning.”
Gregory Alushin reveals fundamental truths about cellular biomechanics by studying how the wiggly protein strands known as actin filaments bend and flex, crisscross each other, and have tugs of war.
They identified a brain signal that guides one type of decision-making—findings that could build a foundation for understanding how humans make educated and strategic decisions.
Fibrolamellar carcinoma not only hinders the body's ammonia consumption but also produces ammonia, a finding with sweeping implications for treating this cancer—and the study of ammonia metabolism.
According to the 2023 CWTS Leiden Ranking of over 1,400 universities from 72 countries, Rockefeller has the highest percentage of most frequently cited scientific publications.
The algorithm, dubbed SCRuB, can distinguish native bacteria and viruses from contaminants—a powerful tool for researchers working with the microbiome.
With this week’s ceremony, Rockefeller has granted Ph.D.s in bioscience to 1,431 students. In addition, Ingrid Daubechies, Marc W. Kirschner, and Evelyn G. Lipper received honorary doctor of science degrees.
The labs of Ali Brivanlou and Charles M. Rice collaborated to refine a cell culture technology platform that grows genetically identical lung buds from human embryonic stem cells.
Research shed light on the process by which the γ-Tubulin Ring Complex stabilizes microtubules, which may inform the study of developmental diseases and cancers.
Why do some with COVID end up on ventilators while others get a scratchy throat—and yet others seem to have dodged the virus entirely? Answers are emerging from scientists around the globe.
Damaged gums may release bacteria into the bloodstream that trigger arthritis flare-ups, potentially explaining why people with gum disease don't respond as well to arthritis treatments.
Universal vaccines can give years of protection against polio, measles, and smallpox, among other diseases. Pamela Bjorkman believes HIV, influenza, and COVID are next.
The tech, dubbed MesoLF, captures 10,500 neurons buried at once-inaccessible depths, firing from brain regions many millimeters apart, simultaneously—all with unprecedented resolution.
The author of Finding the Mother Tree: Discovering the Wisdom of the Forest will be presented with Rockefeller’s prestigious science writing award on April 17.
The relatively simple and low-cost procedure could empower laboratories in low-resource areas to generate nanobodies against SARS-CoV-2, as well as other viruses.
A trio of faulty genes fail to put the brakes on the immune system’s all-out assault on SARS-CoV-2, leading to the inflammatory overload characteristic of MIS-C.
Fuchs receives the honor for illuminating the genetics of skin diseases and the mechanisms that guide skin renewal, yielding insights into aging, inflammation, and cancer.
A diverse immune response hinges on naive B cells mingling with high affinity ones in the late-stage germinal center. Whether that helps or hinders, however, depends on the virus.
Patients with Fanconi anemia have an elevated risk for squamous cell carcinoma, a highly aggressive head-and-neck cancer. New findings pinpoint the mechanisms linking the two conditions, and also shed new light on how smoking or drinking may elevate anyone’s cancer risk.
